- Home
- BNTX vs VTR Comparison
BNTX vs VTR Comparison
Compare BNTX & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- VTR
- Stock Information
- Founded
- BNTX 2008
- VTR 1983
- Country
- BNTX Germany
- VTR United States
- Employees
- BNTX N/A
- VTR N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- VTR Real Estate Investment Trusts
- Sector
- BNTX Health Care
- VTR Real Estate
- Exchange
- BNTX Nasdaq
- VTR Nasdaq
- Market Cap
- BNTX 23.9B
- VTR 25.3B
- IPO Year
- BNTX 2019
- VTR 1998
- Fundamental
- Price
- BNTX $111.50
- VTR $58.68
- Analyst Decision
- BNTX Strong Buy
- VTR Buy
- Analyst Count
- BNTX 15
- VTR 10
- Target Price
- BNTX $143.50
- VTR $61.60
- AVG Volume (30 Days)
- BNTX 802.7K
- VTR 2.5M
- Earning Date
- BNTX 11-04-2024
- VTR 02-12-2025
- Dividend Yield
- BNTX N/A
- VTR 3.07%
- EPS Growth
- BNTX N/A
- VTR N/A
- EPS
- BNTX N/A
- VTR N/A
- Revenue
- BNTX $3,390,698,192.00
- VTR $4,797,115,000.00
- Revenue This Year
- BNTX N/A
- VTR N/A
- Revenue Next Year
- BNTX N/A
- VTR $7.07
- P/E Ratio
- BNTX N/A
- VTR N/A
- Revenue Growth
- BNTX N/A
- VTR 10.05
- 52 Week Low
- BNTX $76.53
- VTR $41.45
- 52 Week High
- BNTX $131.49
- VTR $67.61
- Technical
- Relative Strength Index (RSI)
- BNTX 45.33
- VTR 28.53
- Support Level
- BNTX $112.91
- VTR $61.73
- Resistance Level
- BNTX $123.30
- VTR $62.29
- Average True Range (ATR)
- BNTX 4.70
- VTR 1.19
- MACD
- BNTX -0.62
- VTR -0.31
- Stochastic Oscillator
- BNTX 9.59
- VTR 0.32
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.